X
Novartis and Pear to develop substance use digital therapeutics
https://pharmaphorum.com/news/novartis-digital-therapeutics-sandoz-pear/
Novartis
Novartis invests $100m in new malaria drugs
Concerns are mounting over resistance to artemisinin
Digital health round-up: Theranos’ Holmes charged with ‘massive fraud’
Richard Staines gives a weekly round-up of the developments in digital health
Novartis’ new digital chief joins exec committee
Incoming CEO Vas Narasimhan continues digital health push
Digital Health Round-Up: Novartis and Science 37 hope to cut R&D costs
Richard Staines presents a round-up of the week’s digital health news
Novartis expands virtual clinical trial project with Science 37
Swiss pharma builds on existing collaboration with Science 37
